Law360, New York (July 11, 2006) -- Forest Laboratories Inc. and its Danish licensing partner H. Lundbeck A/S have filed their third separate lawsuit to stop a generic version of the blockbuster antidepressant drug Lexapro from entering the market.
In its complaint filed Monday in the U.S. District Court in Detroit, Forest accused Caraco Pharmaceutical Laboratories Ltd. of infringing its patent when it applied to the Food and Drug...
